| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Total Expenses - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Gross Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Net Profit/Loss - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
Check the financial reports for the company - Conpharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 988 | 978 | 962 | 944 | 926 | 908 | 888 | 891 | - | - |
| Current Assets | 267 | 265 | 260 | 256 | 251 | 246 | 240 | 241 | - | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Receivables | 6 | 6 | 5 | 5 | 5 | 5 | 5 | 5 | - | - |
| Cash | 262 | 259 | 255 | 250 | 245 | 241 | 235 | 236 | - | - |
| Shareholders Funds | -5.593 | -5.536 | -5.442 | -5.342 | -5.239 | -5.140 | -5.026 | -5.041 | - | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | - | - |
| Debts | 6.849 | 6.779 | 6.664 | 6.542 | 6.415 | 6.294 | 6.154 | 6.173 | - | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Conpharma S.r.l.